1. 57 Crizotinib in clinical practice: the North East of England's experience. (January 2016) Authors: Hall, S.; Lambourne, B.; Aynsley, E.; Gardiner, J.; Greystoke, A.; Hughes, A.; Jones, C.; Leaning, D.; Li, L.; Mansy, T.; Margetts, J.; Mcdonald, F.; Mcmenemin, R.; Mulvenna, P.; Peedell, C.; Shakespeare, D.; Simmons, T.; Singhal, S.; Turnbull, H. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 72: Audit of outcomes of NSCLC patients treated with first line EGFR inhibitors in North East England. (January 2015) Authors: Margetts, J.; Smith, E.; Aynsley, E.; Gardiner, J.; Hughes, A.; Jones, C.; Li, L.; Mansy, T.; McDonald, F.; McMenemin, R.; Mulvenna, P.; Peedell, C.; Reay, E.; Simmons, T.; Turnbull, H. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗